Stock listing
A1C9RN Stock Price, News, Filings & Events — Ligand Pharmaceuticals Incorporated
Selected listing: A1C9RN · LS · EUR · DE
This page tracks Ligand Pharmaceuticals Incorporated's A1C9RN:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1C9RN:LS. A1C9RN:LS is the stock-level entry point for investors researching Ligand Pharmaceuticals Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ligand Pharmaceuticals Incorporated (ticker: LGND) is a public company based in the United States, with a market capitalization of approximately $6.02 billion. The company focuses on developing and commercializing technologies that enhance the drug discovery and development process. Ligand partners with various pharmaceutical companies to provide innovative solutions in the biopharmaceutical industry.
- Ticker
- A1C9RN:LS
- Asset type
- Stock
- Market cap
- $5.59B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Ligand Pharmaceuticals Incorporated A1C9RN:LS stock context
This page tracks Ligand Pharmaceuticals Incorporated's A1C9RN:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1C9RN:LS. A1C9RN:LS is the stock-level entry point for investors researching Ligand Pharmaceuticals Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ligand Pharmaceuticals Incorporated (ticker: LGND) is a public company based in the United States, with a market capitalization of approximately $6.02 billion. The company focuses on developing and commercializing technologies that enhance the drug discovery and development process. Ligand partners with various pharmaceutical companies to provide innovative solutions in the biopharmaceutical industry.
Latest news from Ligand Pharmaceuticals Incorporated
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
July 14, 2026
XOMA Royalty Announces Closing of Its Acquisition by Ligand
July 14, 2026
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
June 23, 2026
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031
June 22, 2026
Ligand Pharmaceuticals Incorporated earnings calls
Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Ligand Pharmaceuticals Incorporated (LGND) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Ligand Pharmaceuticals Incorporated (LGND) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Ligand Pharmaceuticals Incorporated (LGND) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated investor report
Review AI stock analysis and investor report context for A1C9RN:LS.
Ligand Pharmaceuticals Incorporated company profile
View the public company page for Ligand Pharmaceuticals Incorporated on 6ix.
Ligand Pharmaceuticals Incorporated news
Read company news and market updates connected to Ligand Pharmaceuticals Incorporated.
Ligand Pharmaceuticals Incorporated investor events
Find investor webinars, events, and replay context for Ligand Pharmaceuticals Incorporated.
Alternate listings
LGND:NASDAQ
US · USD
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:GETTEX
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:TRADEGATE
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
A1C9RN:LSX
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGND:BOATS
US · USD
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:FWB
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:SWB
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:BX
CH · CHF
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:DUS
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.
LGDN:MUN
DE · EUR
Alternate listing for Ligand Pharmaceuticals Incorporated; the primary context on this page is A1C9RN:LS.